HomeInsightsPE

Novartis India Ltd PE Ratio

Novartis India Ltd PE Ratio

Last Updated on: Dec 14, 2024

Image

Novartis India Ltd

NSE: NOVARTIND

PE

28.6

Last updated on: Dec 14, 2024

Key Highlights

  • The P/E Ratio of Novartis India Ltd is 28.6 as of 14 Dec 9.00 AM .
  • The P/E Ratio of Novartis India Ltd changed from 32.7 on March 2019 to 29.8 on March 2024 . This represents a CAGR of -1.54% over 6 years.
  • The Latest Trading Price of Novartis India Ltd is ₹ 1012 as of 13 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Novartis India Ltd

No data available

Company Fundamentals for Novartis India Ltd

No data available

Image

Novartis India Ltd

NSE: NOVARTIND

Share Price

₹ 1012.1

12.40 (1.24%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Novartis India Ltd

1M

1Y

3Y

5Y

Monitoring Novartis India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 20241012.1
12 Dec 2024999.7
11 Dec 20241012.25
10 Dec 20241022.85
09 Dec 20241001.4
06 Dec 20241040.6
05 Dec 20241055.85
04 Dec 20241057.15
03 Dec 20241080.8
02 Dec 20241071.25

SWOT Analysis Of Novartis India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novartis India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Novartis India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Novartis India Ltd282,498
Sun Pharmaceuticals Industries Ltd384,35,179
Divis Laboratories Ltd851,55,995
Cipla Ltd251,16,890
Torrent Pharmaceuticals Ltd651,13,295
Mankind Pharma Ltd501,05,787

Key Valuation Metric of Novartis India Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Novartis India Ltd

No data available

* All values are in crore

Historical Revenue of Novartis India Ltd

No data available

* All values are in crore

Historical EBITDA of Novartis India Ltd

No data available

* All values are in crore

Historical Net Profit of Novartis India Ltd

No data available

* All values are in crore

Historical Dividend Payout of Novartis India Ltd

No data available

* All values are in %

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

Novartis India Ltd News Hub

News

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October ...

Read more

2024-09-28 00:00:00

News

Novartis India standalone net profit declines 13.81% in the September 2024 quarter

Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended Septem...

Read more

2024-10-25 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Novartis India Ltd

What is the current PE Ratio of Novartis India Ltd?

The Current PE Ratio of Novartis India Ltd is 28.59 as on 14 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 14 Dec 2024.

What was the PE Ratio of Novartis India Ltd last year?

The PE Ratio of Novartis India Ltd was 13.5 last year, now the PE ratio is 28.59, showing a year-on-year growth of 111.8%.

What does the PE Ratio of Novartis India Ltd indicate about its stock?

The PE Ratio of Novartis India Ltd is 28.59. This ratio indicates that investors are willing to pay 28.59 times the earnings per share for each share of Novartis India Ltd.

What is the PE Ratio Growth of Novartis India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Novartis India Ltd grew by 111.8% whereas, the EPS ratio grew by -20.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions